RxSight, Inc. Files 8-K for Security Holder Vote

TL;DR

RxSight (RXST) is calling a shareholder vote on June 6th - details to come.

AI Summary

On June 6, 2024, RxSight, Inc. filed an 8-K report to announce the submission of matters to a vote of its security holders. The filing does not disclose the specific matters to be voted on or the date of the security holders' meeting.

Why It Matters

This filing indicates that RxSight, Inc. is convening a meeting for its security holders to vote on important company matters, which could impact the company's future direction or governance.

Risk Assessment

Risk Level: medium — The filing itself is procedural, but the matters to be voted on could carry significant implications for the company's strategic direction, financial health, or corporate governance.

Key Players & Entities

• RxSight, Inc. (company) — Registrant
• June 06, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-40690 (commission_file_number) — SEC File Number
• 94-3268801 (irs_number) — IRS Employer Identification No.
• 100 Columbia (address) — Address of Principal Executive Offices
• Aliso Viejo (city) — City of Principal Executive Offices
• California (state) — State of Principal Executive Offices
• 92656 (zip_code) — Zip Code of Principal Executive Offices
• (949) 521-7830 (phone_number) — Registrant's Telephone Number

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share RXST The Nasdaq Stock Mar

Filing Documents

• rxst-20240606.htm (8-K) — 75KB
• 0000950170-24-069895.txt ( ) — 184KB
• rxst-20240606.xsd (EX-101.SCH) — 23KB
• rxst-20240606_htm.xml (XML) — 4KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. We held our 2024 Annual Meeting of Stockholders ("Annual Meeting") on June 6, 2024. Of the 37,173,544 shares of our common stock outstanding as of April 8, 2024, 30,022,322 shares of common stock were represented, either by attending the virtual annual meeting or by proxy, constituting, of the shares entitled to vote, approximately 80.8% of the outstanding shares of common stock. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below. 1. Election of Three Class III Directors. The following nominees were re-elected by the holders of our common stock to serve as our Class III directors to hold office until our 2027 annual meeting of stockholders and until their successors have been duly elected and qualified: Nominee For Withhold Broker Non-Votes Julie B. Andrews 18,202,611 5,913,897 5,905,814 Robert J. Palmisano 18,202,323 5,914,185 5,905,814 Tamara R. Fountain, M.D. 18,195,702 5,920,806 5,905,814 2. Advisory Vote on Executive Compensation. The stockholders approved, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement based on the following results of voting: For Against Abstain Broker Non-Votes 22,608,292 1,123,950 395,359 5,894,721 3. Advisory Vote on Frequency of Votes to Approve Executive Compensation. The stockholders approved, on an advisory basis, the option of "ONE YEAR" as the frequency with which stockholders are provided an advisory vote on executive compensation based on the following results of voting: One Year Two Years Three Years Abstain Broker Non-Votes 20,463,835 5,400 1,196,918 2,461,448 5,894,721 In accordance with the voting results for this proposal, the Company has determined that the Company will hold future stockholder advisory votes on the compensation of the Company's named executive offic

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. RxSight, Inc. Date: June 6, 2024 By: /s/ Shelley Thunen Name: Shelley Thunen Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR